INC

INC Research, Astellas form multi-year development alliance

Wednesday, April 18, 2012 11:04 AM

INC Research, a therapeutically focused CRO, has entered into a Functional Service Provider (FSP) alliance with Astellas Pharma to drive global consistency, save time and reduce costs for multiple clinical development programs across several therapeutic areas.

More... »

MDI completes $1.9M Series B financing for Detect-Ready tests

Tuesday, April 17, 2012 07:30 AM

Molecular Detection Inc. (MDI), a Berwyn, Penn.-based company developing Detect-Ready tests designed to increase the speed and accuracy of infectious disease diagnosis, has completed a $1.9 million Series B recapitalization financing. 

More... »

INC Research appoints Gaenzle as general counsel

Wednesday, April 11, 2012 03:38 PM

INC Research, a therapeutically focused CRO of Raleigh, N.C., has appointed Christopher L. Gaenzle as its general counsel.  

More... »

Compugen expands to California to develop mAb drug candidates

Monday, April 2, 2012 03:31 PM

Compugen Inc., a Canadian therapeutic product discovery company, has established new operations in South San Francisco, Calif., for the development of oncology and immunology monoclonal antibody (mAb) drug candidates against Compugen-discovered targets.

More... »

INC Research to close Old Lyme office

Wednesday, March 28, 2012 11:12 AM

INC Research, a CRO based in Raleigh, N.C., will be closing its Old Lyme office in Connecticut, laying off 66 employees in the process, according to the filing at the State of Connecticut Labor Department.

More... »

Anaphore acquires RuiYi in Shanghai for GPCR biologics

Friday, March 23, 2012 03:55 PM

Anaphore, a pharmaceutical company based in La Jolla, Calif., has acquired Shanghai-based RuiYi, bringing the company a biologics drug discovery platform focused on biologic therapies targeting G protein coupled receptors (GPCRs). 

More... »

inVentiv to acquire Kforce

Monday, March 19, 2012 12:39 PM

Burlington, Mass.-based inVentiv Health, which offers clinical, commercial and consulting services to the healthcare industry, has signed a definitive agreement to acquire Kforce Clinical Research (KCR), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.

More... »

The CenterWatch Monthly, March 2012

Thursday, March 1, 2012 06:05 AM

Living in a post-M&A world of CROs

More... »

Inclinix and JSW Life Sciences form strategic partnership

Thursday, February 23, 2012 06:16 AM

Inclinix, which specializes in customized phase I-IV clinical enrollment solutions, has selected CRO JSW Life Sciences as its European partner to support enrollment of its clinical trials throughout Europe.

More... »

Rhenovia Pharma opens first U.S. office

Wednesday, January 25, 2012 01:55 PM

Rhenovia Pharma, a biotechnology company specializing in biosimulation to aid discovery of treatments for brain diseases, has formed its first international subsidiary, Rhenovia Inc. The new operation will be based in Cambridge, Mass.

More... »